| Income Statement |
| Total Revenue | 416.17M |
|
| Revenues (USD) | 416.17M |
| Cost of Revenue | 319.74M |
| Gross Profit | 96.43M |
| Operating Expenses | 85.74M |
| Research and Development Expense | 24.07M |
| Selling, General and Administrative Expense | 55.71M |
| Operating Income | 10.69M |
| Interest Expense | 3.29M |
| Income Tax Expense | 2.90M |
| Net Income | 4.42M |
| Net Income Common Stock | 4.42M |
| Net Income Common Stock (USD) | 4.42M |
| Consolidated Income | 4.42M |
| Earnings per Basic Share | 0.14 |
| Earnings per Basic Share (USD) | 0.14 |
| Earnings per Diluted Share | 0.14 |
| Earning Before Interest & Taxes (EBIT) | 10.61M |
| Earning Before Interest & Taxes (USD) | 10.61M |
| Weighted Average Shares | 30.65M |
| Weighted Average Shares Diluted | 31.05M |
| Balance Sheet |
| Cash and Equivalents | 213.17M |
| Cash and Equivalents (USD) | 213.17M |
| Trade and Non-Trade Receivables | 338.85M |
| Current Assets | 880.01M |
| Property, Plant & Equipment Net | 319.57M |
| Total Assets | 1.49B |
| Debt Current | 9.07M |
| Total Debt | 325.08M |
| Current Liabilities | 426.28M |
| Debt Non-Current | 316.01M |
| Total Liabilities | 770.09M |
| Accumulated Retained Earnings (Deficit) | 722.72M |
| Accumulated Other Comprehensive Income | -11.90M |
| Shareholders Equity | 723.12M |
| Shareholders Equity (USD) | 723.12M |
| Assets Non-Current | 613.19M |
| Total Debt (USD) | 325.08M |
| Goodwill and Intangible Assets | 156.81M |
| Inventory | 244.54M |
| Liabilities Non-Current | 343.81M |
| Trade and Non-Trade Payables | 270.38M |
| Tax Assets | 92.96M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 14.52M |
| Net Cash Flow from Financing | 37.76M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 35.77M |
| Capital Expenditure | -8.48M |
| Issuance (Repayment) of Debt Securities | 38.20M |
| Net Cash Flow from Investing | -8.73M |
| Net Cash Flow from Operations | 7.32M |
| Effect of Exchange Rate Changes on Cash | -566.00K |
| Share Based Compensation | 4.74M |